Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LETHE: Lifestyle vs Liraglutide vs Sleeve Gastrectomy in Obesity
NCT03534310Completed
- Sponsor
- Università Cattolica del Sacro Cuore
- Start
- Nov 2015
- Primary completion
- Jan 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label trial of liraglutide in obesity (3 arms), sponsored by Università Cattolica del Sacro Cuore. Primary endpoint: Change of baseline BMI at 1 year. Started Nov 2015; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03534310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03534310.